IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$672M
AUM Growth
+$124M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
266
New
Increased
Reduced
Closed

Top Buys

1
+$23.4M
2
+$15.9M
3
+$15.5M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$15.4M
5
RLMD icon
Relmada Therapeutics
RLMD
+$10.2M

Top Sells

1
+$29.5M
2
+$19.7M
3
+$18.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
5
CLDX icon
Celldex Therapeutics
CLDX
+$15.8M

Sector Composition

1 Healthcare 98.54%
2 Consumer Staples 0.23%
3 Financials 0.12%
4 Industrials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$1.91M 0.06%
610,299
-120,000
102
$1.9M 0.06%
32,137
+27,500
103
$1.88M 0.06%
500,000
104
$1.87M 0.06%
+23,012
105
$1.85M 0.06%
34,587
-13,816
106
$1.84M 0.06%
+15,084
107
$1.81M 0.06%
+25,000
108
$1.77M 0.06%
135,094
-39,183
109
$1.75M 0.06%
701
110
$1.75M 0.06%
+383,373
111
$1.62M 0.05%
6,913
+6,220
112
$1.6M 0.05%
+1,154
113
$1.6M 0.05%
+22,880
114
$1.59M 0.05%
5,700
115
$1.54M 0.05%
400,000
+300,000
116
$1.52M 0.05%
+5,927
117
$1.47M 0.05%
+150,000
118
$1.44M 0.05%
155,599
+98,456
119
$1.37M 0.05%
+165,900
120
$1.36M 0.05%
+14
121
$1.34M 0.05%
300,000
-100,000
122
$1.33M 0.04%
+50,000
123
$1.24M 0.04%
788,014
+750,417
124
$1.22M 0.04%
+120,135
125
$1.14M 0.04%
+3,054
3 4
5
6 7